However, insights into human PC tumor biology show that many patients with advanced disease may exhibit molecular changes in pathways unrelated to AR, such as BRCA1 and BRCA2 mutations, genes involved in DNA repair (BRCA1/2) [93]. This evidence concerns the gene BRCA1 and pachyonychia congenita.